The U.S. point of care drug of abuse (DOA) testing market size was estimated at USD 370.55 million in 2024 and is projected to grow at a CAGR of 9.3% from 2025 to 2033. The market is driven by an increasing need for rapid and on-site drug testing across multiple settings. Point-of-care D... Read More »
July 2025The global esoteric testing market size was estimated at USD 24.6 billion in 2024 and is projected to reach USD 47.98 billion by 2030, growing at a CAGR of 11.8% from 2025 to 2030. The market growth can be attributed to the increasing demand for early disease diagnosis and the rising pre... Read More »
July 2025The U.S. molecular biology enzymes, reagents and kits market size was estimated at USD 5.95 billion in 2024 and is projected to grow at a CAGR of 9.65% from 2025 to 2033. The market is driven by growing burden of chronic diseases and infectious diseases such as sexually transmitted ... Read More »
June 2025The U.S. lateral flow assay market size was valued at USD 2.82 billion in 2024 and is projected to reach USD 4.63 billion by 2033, growing at a CAGR of 6.08% from 2025 to 2033. The rising prevalence of infectious diseases places immense pressure on public health systems worldwide. With i... Read More »
June 2025The U.S. minimal residual disease testing market was estimated at USD 873.66 million in 2024 and is projected to grow at a CAGR of 9.38% from 2025 and 2033, driven by the country’s rising cancer burden and the healthcare system’s growing emphasis on precision medicine. Accord... Read More »
June 2025The global gastric cancer diagnostics market was estimated at USD 1.18 billion in 2024 and is projected to reach USD 2.22 billion by 2033, growing at a CAGR of 7.43% from 2025 to 2033. The market is growing, driven by the rising incidence of gastric cancer, growing emphasis on early dete... Read More »
June 2025The U.S. gastric cancer diagnostics market size was estimated at USD 489.09 million in 2024 and is projected to reach 897.20 million by 2033, and growing at a CAGR of 7.08% from 2025 to 2033. The U.S. gastric cancer diagnostics market is expanding due to advancements in diagnostic techno... Read More »
June 2025The global pharmaceutical sterility testing market size was estimated at USD 1.75 billion in 2024 and is projected to reach USD 4.64 billion by 2033, growing at a CAGR of 11.58% from 2025 to 2033.Increasing government investments, R&D activities, a growing number of drug launches, an... Read More »
June 2025The U.S. Alzheimer’s disease diagnostics market was valued at USD 3.53 billion in 2024 and is expected to grow at a CAGR of 10.6% from 2025 to 2030. This growth is driven by the rising prevalence of Alzheimer’s disease and increasing emphasis on early and accurate diagnosis. ... Read More »
June 2025The global respiratory syncytial virus vaccines market size was estimated at USD 3.51 billion in 2024 and is projected to reach USD 28.39 billion by 2030, growing at a CAGR of 42.17% from 2025 to 2030, due to the rising burden of respiratory syncytial virus (RSV)-related hospitalizations... Read More »
June 2025The U.S. traumatic brain injury biomarkers market size was estimated at USD 409.60 million in 2024, is projected to reach 1,854.73 million by 2033, and is forecasted to grow at a CAGR of 18.8% from 2025 to 2033. The U.S. traumatic brain injury (TBI) biomarkers market is expanding signifi... Read More »
June 2025The global traumatic brain injury biomarkers market size was estimated at USD 1.04 billion in 2024 and is projected to reach USD 4.73 billion by 2033, growing at a CAGR of 18.84% from 2025 to 2033. The market is facing significant growth driven by rising incidents of traumatic brain inju... Read More »
June 2025The U.S. biological safety testing products and services market size was estimated at USD 1.44 billion in 2024 and is expected to grow at a CAGR of 9.88% from 2025 to 2033. The rapid growth of the biopharmaceutical and biotechnology industries in the U.S. is one of the foremost drivers o... Read More »
June 2025The global molecular diagnostics for sexually transmitted diseases (STDs) market size was estimated at USD 3.36 billion in 2024 and is projected to reach USD 6.94 billion by 2030, growing at a CAGR of 8.3% from 2025 to 2033. The increasing incidence of sexually transmitt... Read More »
June 2025The U.S. molecular diagnostics for sexually transmitted diseases market size was estimated at USD 1.11 billion in 2024 and is projected to grow at a CAGR of 7.60% from 2025 to 2033. The growing burden of sexually transmitted diseases (STDs) across the U.S. is a primary growth driver. Acc... Read More »
June 2025The U.S. STI & vaginitis PCR testing market size was estimated at USD 240.72 million in 2024 and is projected to grow at a CAGR of 8.2% from 2025 to 2030. The increasing prevalence of sexually transmitted infections and growing patient awareness are driving demand for advanced diagno... Read More »
June 2025The global shingles vaccine market size was valued at USD 4.25 billion in 2023 and is projected to grow at a CAGR of 15.3% from 2024 to 2030. Market growth is expected to be driven by factors such as the heightened risk of shingles in individuals aged 60 and above and advancements in hea... Read More »
June 2025The global minimal residual disease testing market size was estimated at USD 2.50 billion in 2024 and is projected to reach USD 4.50 billion by 2030, growing at a CAGR of 10.1% from 2025 to 2030. The market for minimal residual disease (MRD) is driven by rising cancer incidence and preva... Read More »
June 2025The global STI and vaginitis PCR testing market size was estimated at USD 660.97 million in 2024 and is projected to reach USD 1,111.9 million by 2030, growing at a CAGR of 9.21% from 2025 to 2030. This is attributed to the rising global incidence of sexually transmitted and vaginal infe... Read More »
June 2025The global oncology companion diagnostic market size was estimated at USD 5.09 billion in 2024 and is projected to reach USD 8.38 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The growth of the market is attributed to the increasing prevalence of cancer, the growing... Read More »
June 2025